(Q62818047)

English

Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Evaluating the Interest of GEP-based Derived Histone Acetylation Score to Identify Myeloma Patients Who Could Benefit From Treatment With HDAC Inhibitor (English)

0 references

0 references

0 references

23 April 2018

0 references

end time

31 December 2018

0 references

number of participants

30

0 references

research intervention

Histone Deacetylase Inhibitors

0 references

research subject recruitment status

unknown

0 references

minimum age

18 year

0 references

study type

observational study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03515915

0 references

(Q62818047)

Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)